Yabao Pharmaceutical Yabao Pharmaceutical Group ( 亚宝药业) is a company that specializes in the production, logistics, and distribution of medicines. | ![]() WuXi AppTec WuXi AppTec (药明康德, formerly known as WuXi PharmaTech) is a company providing research, development, and manufacturing services to discover and manufacture small molecule drugs and cell and gene therapies. | Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. | Chia Tai Tianqing Chia Tai Tianqing (CTTQ, 正大天晴) is a company focused on the research, manufacturing, and distribution of pharmaceuticals. | ||
Founding Date | Founding Date 1978 | Founding Date 1995 | Founding Date 2000 | Founding Date 1985 | Founding Date 1969 |
Type | Type Public | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Yuncheng Shi, CN HQ Beijing, CN Yuncheng, CN Yuncheng Shi, CN | Locations Lianyungang Shi, CN HQ | Locations Shanghai, CN HQ Beijing, CN Changzhou, CN Chengdu, CN Guangzhou, CN Nantong, CN Shanghai, CN see more | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | Locations Lianyungang Shi, CN HQ |
Employees | Employees 4,142 | Employees 8,9891% decrease | Employees 39,4144% decrease | Employees 8,933 | Employees 1961% decrease |
Valuation ($) | Valuation ($) 613.8 m | Valuation ($) N/A | Valuation ($) 20.7 b | Valuation ($) 4.2 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) ¥2.8b (FY, 2023) | Revenue (est.) ¥12.3b (FY, 2024) | Revenue (est.) ¥37.6b (FY, 2024) | Revenue (est.) ¥11.6b (FY, 2024) | Revenue (est.) N/A |
Cost of goods | Cost of goods ¥1.2b (FY, 2023) | Cost of goods ¥704.1m (FY, 2024) | Cost of goods ¥23b (FY, 2024) | Cost of goods ¥4.1b (FY, 2024) | Cost of goods N/A |
Gross profit | Gross profit ¥1.6b (FY, 2023) | Gross profit ¥11.6b (FY, 2024) | Gross profit ¥16b (FY, 2024) | Gross profit ¥7.6b (FY, 2024) | Gross profit N/A |
Net income | Net income ¥179.9m (FY, 2023) | Net income ¥4.4b (FY, 2024) | Net income ¥9.6b (FY, 2024) | Net income ¥2.3b (FY, 2024) | Net income N/A |
Operating ⚠ | |||||
Trademarks | Trademarks 51 (Sep, 2023) | Trademarks N/A | Trademarks N/A | Trademarks 45 (Sep, 2023) | Trademarks N/A |
Jiangsu Hansoh Pharmaceutical Group is a pharmaceutical company.
View companyWuXi AppTec (药明康德, formerly known as WuXi PharmaTech) is a company providing research, development, and manufacturing services to discover and manufacture small molecule drugs and cell and gene therapies.
View companyLivzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View companyChia Tai Tianqing (CTTQ, 正大天晴) is a company focused on the research, manufacturing, and distribution of pharmaceuticals.
View company